[MYGN] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 623.40%
YoY- 261.84%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 179,300 164,900 160,800 167,300 189,400 173,100 154,600 10.41%
PBT -17,900 -26,400 -43,500 39,800 -3,800 -49,600 -55,700 -53.18%
Tax -3,800 -5,900 -35,900 15,200 900 -10,100 -11,500 -52.30%
NP -14,100 -20,500 -7,600 24,600 -4,700 -39,500 -44,200 -53.41%
Tax Rate - - - -38.19% - - - -
Total Cost 193,400 185,400 168,400 142,700 194,100 212,600 198,800 -1.82%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -7.86 -12.43 -4.73 14.70 -2.48 -22.82 -28.59 -57.81%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.18 -0.26 -0.10 0.31 -0.06 -0.52 -0.59 -54.77%
EPS Diluted -0.18 -0.26 -0.10 0.30 -0.06 -0.52 -0.59 -54.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.